Further multicentric studies are needed to confirm our findings, verify the utility of target genes as targets of therapy, and better understand the molecular role of IFNG-AS1 and GAS5 in the etiology and pathogenesis of childhood ITP. Here, GAS5 is linked to autoimmune thrombocytopenic purpura.